Showing results (151-160 of 188) with videos related to
Sort By:
Pageof 19
Plos One|April 25, 2018
Phase I/II evaluation of RV1001, a novel PI3Kδ inhibitor, in spontaneous canine lymphomaHeather L Gardner, Sarah B Rippy, Misty D Bear, et al.International Journal of Radiation Oncology, Biology, Physics|April 13, 2000
Accelerated superfractionated radiotherapy for inflammatory breast carcinoma: complete response predicts outcome and allows for breast conservationD W Arthur, R K Schmidt-Ullrich, R B Friedman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project C-04N Wolmark, H Rockette, E Mamounas, et al.Journal of Leukocyte Biology|March 11, 2014
Mast cell histamine promotes the immunoregulatory activity of myeloid-derived suppressor cellsRebecca K Martin, Sheinei J Saleem, Lauren Folgosa, et al.BMC Immunology|February 29, 2020
The DNA methyltransferase inhibitor, guadecitabine, targets tumor-induced myelopoiesis and recovers T cell activity to slow tumor growth in combination with adoptive immunotherapy in a mouse model of breast cancerAndrea J Luker, Laura J Graham, Timothy M Smith, et al.Breast Cancer Research and Treatment|April 12, 2011
A signature of immune function genes associated with recurrence-free survival in breast cancer patientsMaria Libera Ascierto, Maciej Kmieciak, Michael O Idowu, et al.International Journal of Radiation Oncology, Biology, Physics|June 6, 2003
Partial breast brachytherapy after lumpectomy: low-dose-rate and high-dose-rate experienceDouglas W Arthur, Derrick Koo, Robert D Zwicker, et al.Breast Cancer Research : BCR|October 29, 2020
Local and distant tumor dormancy during early stage breast cancer are associated with the predominance of infiltrating T effector subsetsHussein F Aqbi, Cara Coleman, Melika Zarei, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 12, 2006
Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer:National Surgical Adjuvant Breast and Bowel Project Protocol B-27Harry D Bear, Stewart Anderson, Roy E Smith, et al.Cancer Research|March 17, 2021
Engineering T Cells to Express Tumoricidal MDA-7/IL24 Enhances Cancer ImmunotherapyZheng Liu, Chunqing Guo, Swadesh K Das, et al.Pageof 19